Physiomics plc (PYC) ORD GBP0.004
Share news, reports & tips
21 May 2021 09:53
(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it has been awarded two further contracts by existing client Bicycle Therapeutics.
14 May 2021 08:27
(Sharecast News) - Drug development consultancy Physiomics has been awarded a further contract with a leading science and technology company Merck.
11 May 2021 10:46
(Sharecast News) - Consultancy firm Physiomics said on Tuesday that it has been awarded a first contract with new client Numab Therapeutics.
10 May 2021 08:40
(Sharecast News) - Technology-based solutions provider Physiomics said on Monday that total income for the financial year ending 30 June was likely to be below market expectations due to both Covid-19...
15 February 2021 16:04
(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the...
17 December 2020 13:59
(Sharecast News) - Oncology consultancy Physiomics announced on Thursday that its existing client, Merck, has committed to an initial tranche of projects for 2021 with a total value of £0.27m.
16 October 2020 09:30
(Sharecast News) - Oncology consultancy Physiomics has been awarded further contracts of an undisclosed value for projects with existing clients Bicycle Therapeutics and Merck.
31 July 2020 12:08
(Sharecast News) - Oncology consultancy Physiomics announced on Friday that it has been awarded a contract by a new client, Japan-based global pharmaceutical company Astellas Pharma.
27 May 2020 10:30
(Sharecast News) - Oncology consultancy Physiomics has raised roughly £829,000 through a share issue to finance further development.
10 March 2020 11:39
(Sharecast News) - Oncology consulting company Physiomics has received a 'Connect' award from the National Institute for Health Research's (NIHR) 'Invention for Innovation' (i4i)...
3 March 2020 10:19
(Sharecast News) - Oncology consultancy Physiomics said on Tuesday that interim losses had widened despite posting an improvement in revenues.
23 December 2019 08:33
(Sharecast News) - Oncology consultancy business Physiomics has been awarded a further project agreement with British biotech outfit CellCentric.
Company announcements Announcements
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2021. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.